Cooley, Latham Steer Turnstone Biologics' $86M IPO Filing
Cancer-focused startup Turnstone Biologics Corp. filed an estimated $86 million initial public offering this week, represented by Cooley LLP and underwriters counsel Latham & Watkins LLP amid a slump in IPO...To view the full article, register now.
Already a subscriber? Click here to view full article